BOSTON – (March 12, 2015) – Joslin Diabetes Center and Daegu-Gyeongbuk Free Economic Zone (DGFEZ) have signed a memorandum of understanding (MOU) formalizing their mutual strong commitment to navigate avenues for potential partnership. 

This MOU was written after Joslin CEO John L. Brooks III and Joslin’s International team met with DGFEZ Commissioner Gunwoo Do this past December to discuss opportunities to collaborate, including information about the DGFEZ’s healthcare infrastructure and operating environment. 

The MoU signing is an important step towards establishing a partnership that will allow Joslin to potentially establish a physical presence in the Daegu-Gyeongbuk area, bringing Joslin’s mission of preventing, treating and curing diabetes to the region.

“The MOU is a critical step in demonstrating Joslin’s commitment to explore opportunities with DGFEZ to make an impact on diabetes prevention and treatment in the region,” said William C. Hsu, M.D., Vice President of International Programs at Joslin and Assistant Professor at Harvard Medical School. “DGFEZ has a comprehensive plan to establish an ecosystem for world-class medical care. Joslin looks forward to a potential public-private partnership, including the opportunity to integrate technology with diabetes care in a country known for impressive advancements in communication technology.” 

There were an estimated 2.7 million cases of diabetes in the Republic of Korea in 2014. 

DGFEZ Commissioner Gunwoo Do expressed his strong commitment to working with Joslin in making the city of Daegu a central place for healthcare services on diabetes, clinical trials and diabetes research in Asia. “The MOU reflects the two organizations’ relationship founded on trust and mutual benefits to make the world free of diabetes, and the city of Daegu is ready to contribute to the valuable cause with the help of Joslin’s advanced research capability and authoritative expertise on diabetes,” said the Commissioner Do.

Joslin representatives and DGFEZ’s officials originally began discussions in December of 2013. Active discussions continued and the newly appointed DGFEZ commissioner, Gunwoo Do, flew to Boston to showcase DGFEZ’s continued, strong commitment to working with Joslin. Commissioner Gunwoo Do views the MOU as an important and valuable starting point to navigate ways to attract Joslin into the Daegu-Gyeongbuk area. DGFEZ plans to closely collaborate with the Daegu Metropolitan City government and the Ministry of Health and Welfare to provide full support to Joslin. 

###

Related Articles

A Scientist working in lab
Type 1
Kidney Disease
Research Highlights

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

Three-year clinical trial finds reducing uric acid levels in type 1 diabetes provides no beneficial impact on the progression of diabetic kidney disease BOSTON – (November 8, 2019) – Diabetic kidney...
Read more on The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion
National Diabetes Month
Type 1
Type 2

National Diabetes Awareness Month

National Diabetes Awareness Month

Diabetes is growing at an epidemic rate in the United States and across the globe. According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans have diabetes and 1.5...
Read more on National Diabetes Awareness Month
Red blood cell traveling in an artery
Type 1
Heart Disease
Research Highlights

Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment